Proton Beam Therapy Alone for Intermediate- or High-Risk Prostate Cancer: An Institutional Prospective Cohort Study

The role of proton beam therapy (PBT) as monotherapy for localized prostate cancer (PCa) remains unclear. The purpose of this study was to evaluate the efficacy and adverse events of PBT alone for these patients. Between January 2011 and July 2014, 218 patients with intermediate- and high-risk PCa w...

Descripción completa

Detalles Bibliográficos
Autores principales: Arimura, Takeshi, Yoshiura, Takashi, Matsukawa, Kyoko, Kondo, Naoaki, Kitano, Ikumi, Ogino, Takashi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5923371/
https://www.ncbi.nlm.nih.gov/pubmed/29642619
http://dx.doi.org/10.3390/cancers10040116

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5923371/
https://www.ncbi.nlm.nih.gov/pubmed/29642619
http://dx.doi.org/10.3390/cancers10040116

Ejemplares similares